Incyte Corporation (INCY) 의 후행 P/E는 14.6, 선행 P/E 13.3. 후행 이익수익률은 6.85%, 선행 이익수익률 7.54%. PEG 0.90 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $61.87.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 82/100 6/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 180.7 | 0.14 | 44.91 | 17.04 | - |
| 2017 | -61.9 | 0.16 | 11.88 | 12.61 | - |
| 2018 | 123.3 | -0.92 | 7.01 | 7.18 | - |
| 2019 | 42.0 | 0.14 | 7.22 | 8.69 | - |
| 2020 | -64.1 | 0.39 | 7.26 | 7.11 | - |
| 2021 | 17.1 | -0.04 | 4.29 | 5.42 | - |
| 2022 | 52.3 | -0.81 | 4.08 | 5.25 | - |
| 2023 | 23.5 | 0.32 | 2.71 | 3.80 | - |
| 2024 | 438.6 | -4.67 | 4.15 | 3.37 | - |
| 2025 | 15.0 | 0.00 | 3.73 | 3.75 | - |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $0.54 | $1.11B | $104.22M | 9.4% |
| 2017 | $-1.53 | $1.54B | $-313.14M | -20.4% |
| 2018 | $0.51 | $1.88B | $109.49M | 5.8% |
| 2019 | $2.05 | $2.16B | $446.91M | 20.7% |
| 2020 | $-1.36 | $2.67B | $-295.7M | -11.1% |
| 2021 | $4.27 | $2.99B | $948.58M | 31.8% |
| 2022 | $1.52 | $3.39B | $340.66M | 10% |
| 2023 | $2.65 | $3.7B | $597.6M | 16.2% |
| 2024 | $0.15 | $4.24B | $32.62M | 0.8% |
| 2025 | $6.41 | $5.14B | $1.29B | 25% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $7.43 | $6.78 – $7.71 | $5.57B | $5.48B – $5.76B | 15 |
| 2027 | $8.98 | $8.01 – $11.10 | $6.21B | $5.81B – $7.32B | 15 |
| 2028 | $9.61 | $6.19 – $12.72 | $6.49B | $6.47B – $6.5B | 11 |
| 2029 | $3.52 | $3.32 – $4.06 | $4.59B | $4.39B – $5.13B | 4 |
| 2030 | $4.03 | $3.80 – $4.65 | $4.75B | $4.54B – $5.3B | 4 |
